LIGAND PHARMACEUTICALS INCORPORATED Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
LIGAND PHARMACEUTICALS INCORPORATED (LGND) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-08-07
- LIGAND PHARMACEUTICALS INCORPORATED right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-12-31 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $2.31M, a 30.86% increase from fiscal 2024.
- LIGAND PHARMACEUTICALS INCORPORATED right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $1.77M.
- LIGAND PHARMACEUTICALS INCORPORATED right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $0.00.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $0.00 10-Q · filed 2026-08-07 | $0.00 derived: sum of 3 quarters · filed 2026-08-07 | $0.00 derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-08 | $0.00 derived: sum of 2 quarters · filed 2026-05-08 | $0.00 derived: sum of 3 quarters · filed 2026-05-08 | $1.49M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $0.00 derived: sum of 2 quarters · filed 2026-02-27 | $1.49M derived: sum of 3 quarters · filed 2026-08-07 | $2.31M 10-K · filed 2026-02-27 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $1.49M derived: sum of 2 quarters · filed 2026-08-07 | $2.31M 10-Q · filed 2025-11-07 | $2.31M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $1.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $2.31M 10-Q · filed 2026-08-07 | $2.31M derived: sum of 3 quarters · filed 2026-08-07 | $2.35M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $828.00K 10-Q · filed 2026-05-08 | $828.00K derived: sum of 2 quarters · filed 2026-05-08 | $860.00K derived: sum of 3 quarters · filed 2026-05-08 | $2.60M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $32.00K derived: sum of 2 quarters · filed 2026-02-27 | $1.77M derived: sum of 3 quarters · filed 2026-02-27 | $1.77M 10-K · filed 2026-02-27 |
| 2024-09-30 | $32.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $1.77M derived: sum of 2 quarters · filed 2025-11-07 | $1.77M 10-Q · filed 2025-11-07 | $1.77M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $1.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $1.74M 10-Q · filed 2025-08-08 | $1.74M derived: sum of 3 quarters · filed 2026-02-27 | $1.74M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-09 | $0.00 derived: sum of 2 quarters · filed 2026-02-27 | $0.00 derived: sum of 3 quarters · filed 2026-02-27 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $0.00 derived: sum of 2 quarters · filed 2026-02-27 | $0.00 10-K · filed 2026-02-27 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $0.00 10-Q · filed 2024-11-08 | ||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-07 | |||
| 2022-12-31 | $0.00 10-K · filed 2025-02-28 | |||
| 2021-09-30 | $8.70M 10-Q · filed 2021-11-09 | $8.70M 10-Q · filed 2021-11-09 |